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1. Introduction 
Photodermatoses are a group of skin diseases caused or exacerbated by light. Their 
classification is traditionally based on the cause of the disorder and on the pathology of 
cutaneous response. Polymorphic light eruption (PLE) is the commonest photosensitive 
disorder affecting up to 20% of the population, characterized by an intermittent eruption of 
non scarring pruritic erythematous papules, vesicles or plaques that develop on ultraviolet 
(UV) radiation (UVR)-exposed skin (Stratigos et al., 2002). The course of the disease is 
mainly chronic. The disease is multifactorial: a genetic susceptibility has been identified as 
well as environmental components. The spectrum of radiation that induces PLE is most 
commonly UVA and/or UVB wavelengths and, rarely, visible light. Epstein first 
hypothesized, over 60 years ago, that PLE was an immune-mediated disease. He postulated 
that PLE was a delayed-type hypersensitivity reaction (DTHR) to UVR induced cutaneous 
antigens (Epstein, 1986). Only during the past 20 years have studies emerged that support 
this theory. It is hypothesized that the DTHR associated with PLE is secondary to a partial 
failure of UVR-induced immunosuppression in patients with PLE. Multiple studies 
highlighted the greater role of Langerhans cells (LCs) in the sensitization phase and 
therefore suggested that LC dysfunction may be the underlying cause of PLE. In fact, in 
patients with PLE, LCs persist in the epidermis after intermittent UVB exposure whereas, in 
normal subjects, LCs disappear from the epidermis. In contrast, neutrophil infiltration in the 
skin after UVB exposure is significantly decreased in patients with PLE. Less neutrophilic 
infiltration may lead to impaired local production of cytokines such as interleukin (IL)-4 and 
IL-10. Altering the local skin milieu after UVR exposure eventually leads to activation of the 
skin immune response instead of suppression (Cooper et al., 1992). These observations 
would lead one to suppose that failure of immunosuppression following UVR exposure 
might give an advantage with regard to recognition of UV-induced tumour antigens and 
more effective elimination of such antigenic cells by the immune system. UVR-induced skin 
cancer (SC) is the most prevalent form of human neoplasm. It is well known that UVB (280–
320 nm) and UVA (320-400 nm) radiation can induce DNA damage leading to melanoma or 
non melanoma SC by provoking mutations and immunosuppressive effects. The molecular 
changes induced by UV generate multiple consequent or concomitant mechanisms: DNA 
damage with thymidine dimer formation, urocanic acid (UCA) isomerization from trans-
UCA to cis-UCA, depletion of some protective cytokines such as IL-1, IL-12 and interferon-γ 
(IFN-γ), or the increase of tumour necrosis factor-α (TNF-α), IL-6, IL-10 and IL-15, resulting 
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in the immunosuppressed skin milieu that permits and maintains the proliferation of 
mutated cellular clones (Kamiya, 2003). It would seem that the skin performs a ‘balancing 
act’ between adequate elimination of early cancerous cells and suppression of abnormal 
reactions against UV-exposed cells that may suffer transient aberrations. PLE appears to be 
associated with an ‘imbalance’ between UV-induced proinflammatory and UV-induced 
suppressive immunoreaction. From previous experiences, a reduced incidence of SC has 
been shown in patients with PLE compared with gender- and age-matched controls (Lembo 
et al., 2008). In support of the findings of this study, other studies indicated that either LC 
subtypes or tumour-derived cytokines play a crucial role in UV-induced skin tumours, 
determining LC depletion, attraction and immunoprotective function. Whereas there is 
considerable circumstantial evidence that disruption in the density and function of these 
cells, during the early stages of UVR-induced carcinogenesis, may be important for enabling 
developing neoplasms to escape immune destruction, the role of the large number of these 
cells found infiltrating developed skin tumours, remains unclear. Our aim was to provide an 
overview of UVR effects, photodermatoses and skin cancer, their epidemiology, incidence 
and the relationship of UVR-induced imbalance between immunosuppression or 
immunoactivation in PLE with relative skin cancer risk 
2. Ultraviolet radiation 
Sunlight is a continuous spectrum of electromagnetic radiation that is divided into three 
major spectrums of wavelength: ultraviolet, visible and infrared. The UV range is the most 
significant spectrum of sunlight that causes photoaging and skin cancer. UVR is subdivided 
into: ultraviolet A [UVA (320–400 nm)], ultraviolet B [UVB (280–320 nm)] and ultraviolet C 
[UVC (100–280 nm)]. UVA represent the 90–99% of the solar UVR energy that reaches the 
earth’s surface; it is not filtered by the stratospheric ozone layer in the atmosphere and has 
long wavelength and low energy so it can penetrate deeper into the skin. Once considered 
harmless, but now believed to be harmful, in case of excessive and long-term exposure, 
causes skin aging and induces immediate and persistent pigmentation (tanning). In the 
recent years a carcinogenic role for UVA has also been proved. Only approximately 1–10% 
of UVB reaches the earth’s surface because it is filtered by the stratospheric ozone layer in 
the atmosphere; it has short wavelength and high energy so it can penetrate the upper layers 
of the epidermis. UVB is responsible for sunburns, tanning, wrinkling, photoaging and skin 
cancer. UVC is filtered by the stratospheric ozone layer in the atmosphere before reaching 
earth; the major artificial sources are germicidal lamps. UVC burns the skin and causes skin 
cancer. Ultraviolet radiation that reaches the earth’s surface can increase or decrease based 
on a variety of factors. One factor is the ozone layer, which forms a thin shield in the 
stratospheric atmosphere, protecting life on earth from the sun’s UV rays; this layer absorbs 
all UVC radiation, most UVB radiation and very little UVA radiation. Since the mid 1980s, 
scientists began to be concerned that the ozone layer was being depleted. The reason for 
thinning of the stratospheric ozone is resulting from the release of ozone-depleting 
substances and chemicals (chlorofluorocarbons) that are released from industry and motor 
vehicle into the atmosphere. An approximate 1% decrease in ozone levels corresponds to a 
1–2% increase in the mortality caused by melanoma (World Health Organization, 2009). 
Likewise, a 10% decrease in the ozone levels will cause 300,000 new non-melanoma and 
4500 new melanoma skin cancer cases moreover, multiple factors such as time of the day, 
time of the year, latitude and altitude, determine UVR levels reaching earth’s surface.  
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Depletion of the ozone layer results in increased UVR, (especially UVB) reaching the earth’s 
surface. UVB is directly absorbed by DNA and causes structural DNA damage. UVA causes 
indirect DNA damage through the formation of reactive oxygen species, which create 
breaks in DNA. These events lead to mutations and then to skin cancer (Brenner et al., 2008). 
The sun exerts its highest peak between 10 AM to 4 PM. During this time, the sun’s rays 
have the least distance to travel through the atmosphere and UVB levels are at their highest. 
In the early morning and late afternoon, the sun’s rays pass through the atmosphere at an 
angle and their intensity is greatly reduced. The sun’s angle varies with the seasons, causing 
the intensity of UV rays to change. UV intensity tends to be the highest during the summer 
season. Environmental factors that increase the amount of UVR exposure to humans include 
latitudes closer to the equator. At higher latitudes the sun is lower in the sky, so UV rays 
must travel a greater distance through ozone-rich portions of the atmosphere and in turn, 
less UVR is emitted. Hence, living closer to the equator increases UV exposure, thus 
increasing the incidence of skin cancers. For every 1000 meters increase in elevation, the 
UVR intensity increases by 10–12%. UV levels also depend on cloud cover; thus, there are 
lower UV levels at higher cloud cover densities. In the summer, the sun is higher in the sky, 
and less ultraviolet radiation is absorbed during its passage through the atmosphere. Fog, 
haze, clouds and pollutants can reduce ultraviolet levels by 10–90%. Snow, sand and metal 
can reflect up to 90% of ultraviolet radiation. Sea water can reflect up to 15%, whereas little 
reflection occurs on still water (e.g., a pool). Shade alone reduces solar UVR by 50–95%. The 
amount of protection varies considerably between different shades settings, with a beach 
umbrella showing the least and dense foliage the most protection. The best technique for 
reducing ultraviolet exposure is to avoid the sun, especially in the middle of the day 
(Lautenschlager et al., 2007) . There is accumulating evidence that UVR in physiological 
doses exerts multiple effects on the immune system: such as inducing immune system but 
suppressing the adaptive one. Both effects may be beneficial, protecting from microbial 
infections on the one hand and toning down allergic and autoimmune reactions on the other 
hand; but these effects on the immune system are also responsible of the dangerous effects 
of UVR such as photodermatoses and skin cancer.   
2.1 UVR effects 
Solar UVR makes up just 5% of the electromagnetic spectrum that reaches the earth’s 
surface. Three spectral regions have been designated based on their biological effects. 
Terrestrial UVR consists of 3– 6% UVB and 94– 97% UVA. Negligible amounts of UVC reach 
the earth’s surface due to the filtering capacity of the ozone layer (Diffey, 2002). UVR is a 
potent environmental carcinogen and is largely responsible for the development of the most 
common cancer worldwide: skin cancer. The steady increases in melanoma and non-
melanoma skin cancer cases, contrast with the recent downward incidence for all other 
cancers (excluding lung cancer in women). The increases in skin cancer are largely 
attributed to recreational sun exposure (including tanning beds) practiced by the 
population. Concern that further increases in skin cancer incidence may result due to ozone 
depletion, may be tempered by positive global efforts to reduce ozone-depleting substances 
in the atmosphere (Jemal et al., 2007). The genetic mechanisms by which UVR transforms 
and promotes various skin cancers have been under intense investigation for decades, and 
much progress has been made in identifying genes that contribute to the oncogenic process 
in the development of melanoma, squamous cell carcinoma (SSC) and basal cell carcinoma 
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(BCC). However, in addition to generating genetic mutations, UVR actively suppresses the 
normal processes of immune surveillance responsible for eliminating mutant cells, and 
permits tumor growth. UVR is highly mutagenic but is only partially absorbed by the outer 
stratum corneum of the epidermis Depending on melanin content UVR can penetrate into 
the deeper layers of the epidermis, where induces DNA damage and apoptosis in epidermal 
cells, including those in the germinative basal layer. The cellular decision, to initiate either 
the cellular repair processes or undergo apoptosis, has evolved to balance the acute need to 
maintain skin barrier function with the long-term risk of retaining precancerous cells. 
Langerhans cells are positioned suprabasally, where they may sense UV damage directly, or 
indirectly through recognition of apoptotic vesicles and soluble mediators derived from 
surrounding keratinocytes. Apoptotic bodies will contain UV-induced altered proteins 
(enzymes, proteins that regulate cells proliferation and apoptosis process) that may be 
presented to the immune system as foreign. The observation that UVR induces immune 
tolerance to skin-associated antigens suggests that this photodamage response has evolved 
to preserve the skin barrier by protecting it from autoimmune attack. LC involvement in this 
process is not clear and controversial. In order to ameliorate the world-wide burden of UVR 
related pathologies such as sunburn, aging, autoimmunity, immune suppression and skin 
cancer, it is imperative that we gain a better understanding of the mechanisms of UVA and 
UVB induced photodamage and how they relate to the molecular and immunologic nature 
of photodamage responses. 
2.1.1 The link between UV-induced inflammation and carcinogenesis 
UV augments blood flow and infiltration by blood leukocytes, such as macrophages and 
neutrophils into the skin, observed clinically as inflammation. Increased production of NO 
and prostaglandins contribute to these events. UVR-induced lipid peroxidation increases 
production of prostaglandins (PG), including PGE2, which, in turn, cause inflammation in 
the skin. PGE-2 is produced from arachidonic acid by the inducible form of cyclooxygenase 
(COX), COX-2. This is thought to be due to UV increasing phospholipase activity, thus 
enhancing arachidonic acid availability for PG production. Dietary supplementation with 
fish oils has been shown to reduce UV-induced inflammation in humans, probably due to a 
reduction in UV-induced PGE-2 production. Other UV-induced mediators, such as tumour 
necrosis factor and interleukin 1 also contribute to UV-induced inflammation. The 
inflammatory cells, infiltrating UV exposed skin, produce ROS that further drive damage to 
lipids, proteins and DNA. Thus, UV-induced oxidative damage to lipids, and activation of 
NO synthase (Warren, 1994) initiates a cascade of events resulting in inflammation, which 
causes further reactive oxygen stress in the skin. As ROS produced by inflammatory cells is 
linked to gene mutations, it seems to be a reasonable hypothesis that UV-induced 
inflammation results in genetic damage, which contributes to photocarcinogenesis. There is 
a large amount of literature supporting a role for inflammation in driving tumour 
progression, and anti-inflammatory drugs have been shown to reduce the incidence of 
cancer (Balkwill & Mantovani, 2001). A number of animal models have shown that 
inhibition of COX-2 helps prevent skin cancer: Celecoxib, a COX-2 inhibitor, decreases 
macrophages and neutrophils infiltration into skin tumours; Indomethacin, which inhibits 
both COX-1 and 2, reduces photocarcinogenesis in mice. The cancer protective effect of 
COX-2 inhibition may be due to prevention of inflammation:  it has been suggested, in fact, 
that this may enhance apoptosis of UV damaged keratinocytes as PGE2 signalling is 
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required for growth of skin tumour cells (Thompson et al., 2001). UV-induced infiltration of 
the skin by granulocytes and macrophages has been shown to enhance the growth of a UV-
induced regressor skin tumour. UV-induced regressor skin tumours grow for about 1–2 
weeks after transplantation into syngeneic mice before being rejected by the immune 
system, so that they decrease in size after this time. In these studies, a single inflammatory 
dose of UVR caused infiltration of the skin by CD11b+, Gr-1+, CD45+, MHC Class II+ cells, 
which were likely to be macrophages and or granulocytes (Thompson et al., 2001). Time 
courses demonstrated an enhancement of tumour growth only when these cells were 
present at high numbers in the skin: therefore UV-induced inflammatory cells promoted 
skin tumour growth. Other studies have shown that UV radiation induces infiltration of 
neutrophils and macrophages into the skin of mice and humans. As UV-induced 
inflammatory cells produce hydrogen peroxide and NO, it is likely that ROS produced by 
these inflammatory cells contribute to skin tumour development at least in part by 
enhancing gene mutation, but they may also suppress immunity. Moreover, it has also been 
suggested that inflammatory cytokine induction of iNOS results in increased NO 
production which inhibits DNA repair, thus promoting carcinogenesis. Both of these are 
likely to contribute to skin cancer formation. 
2.1.2 UV-induced oxidative damage and gene mutation 
There is little direct evidence for oxidative damage to DNA making a substantial 
contribution to photocarcinogenesis. 
The formation of micronuclei is an indication of chromosomal rearrangement or genetic 
instability. UVA-induced micronucleus formation in cultured HaCaT cells was reduced by 
treatment with catalase, suggesting a role for hydrogen peroxide in this form of UVA-
induced genetic damage (Phillipson et al., 2002). UVB absorbed by two adjacent cytosine (C) 
residues in DNA causes the formation of cyclobutane pyrimidine dimers (CPD), which 
result in GC to AT mutations. These only occur in response to UVB and can be regarded as 
fingerprints for UVB; UVA-induced CPD formation is orders of magnitude less frequent. In 
contrast, UVA indirectly induces the fingerprint mutations AT to CG at high frequency, but 
these rarely result from UVB or other mutagens. Reactive oxygen and nitrogen species can 
cause many different types of gene mutations, but guanine is the most sensitive of the DNA 
bases to oxidation, as it has the lowest oxidation potential. Hence, G to T, G to C and G to A 
mutations at sites other than dipyrimidines are frequently caused by ROS (Kamiya, 2003). 
However, ROS cannot be assigned to be the mutagen as confidently in these cases as UVB 
and UVA can be identified when the fingerprints mentioned above are observed. UVA itself 
can cause oxidation of guanine indirectly via ROS production, or the ROS can come from 
other sources such as inflammatory cells. However, in combination with UVA-induced 
fingerprints to account for the role of UVA, mutations at guanine sites can give an indication 
of the likely extent to which DNA is mutated in response to ROS from sources other than 
UVA, such as inflammatory cells. In a recent study, different regions of about 20 
keratinocytes from human solar keratosis (SK) and SCC were microdissected to analyse the 
p53 gene for mutations. Using the criteria described above, the mutations could be grouped 
into those most likely caused by ROS, UVB or UVA. When the cause of the mutations could 
not be unambiguously identified they were grouped as “other”, but some of these could 
have been due to ROS, UVB or UVA. About one-third of the mutations in SK were caused 
by sunlight with an equal number resulting from UVA and UVB. ROS caused a slightly 
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larger number of mutations than UV, showing that ROS make a significant contribution to 
the mutational burden in these benign pre-malignant lesions. When comparing SK to SCC, it 
was found that SCC contained an increase in mutational burden of 14 ROS, 5 other, 4 UVB, 
but 0 UVA-induced mutations (Agar et al., 2004). Thus, ROS appear to be responsible for the 
majority of the increase in mutations as SK progress into SCC. UV does not appear to be the 
major mutagen driving SK progression towards SCC, as there was little difference in UVB 
and UVA fingerprints between these lesions. Therefore, the increase in ROS induced 
mutations probably did not result from UVA-induced ROS. This data appear to indicate that 
the mixture of UVA and UVB in sunlight is largely responsible for the mutations that lead to 
SK, but the main factor that then drives these benign lesions to progress to malignancy is 
ROS. The cause of a large number of the mutations could not be identified, and therefore 
some caution is required in interpreting this data. These mutations could have been caused 
by UVB, UVA or ROS, but were not identifiable as such, or they may have resulted from a 
yet unknown event. It has been reported that patients with SK have reduced plasma 
antioxidant defence (Vural et al., 1999), which may contribute to oxidation induced gene 
damage in SK. Most SK do not develop into SCC and often spontaneously regress. 
However, an inflammatory response, developing for unknown reasons in a small subset of 
SK appears to be associated with progression towards malignant SCC. The major mutagen 
driving SK progression to SCC appears to be ROS, rather than sunlight, suggesting that 
reactive oxygen and nitrogen species from inflammatory cells is responsible for progression 
of SK into SCC. While UVA can cause gene mutations indirectly, via reactive oxygen 
mediated processes, the absence of a large increase in UVB-induced gene mutations as SK 
progress towards SCC suggests that little of the ROS-mediated damage driving progression 
of SK to SCC arose from sunlight. 
2.1.3 UV-induced immunosuppression 
Ultraviolet radiation not only causes DNA damage but also is a potent immunosuppressive 
agent. This was demonstrated in a series of elegant experiments carried out by Kripke 
(Fisher & Kripke, 1977). In syngeneic mice, UVR-induced skin cancers were transplanted 
into mice which were either irradiated with UVB or not irradiated. In those mice irradiated 
with UVB the tumours continued to grow, whereas those not irradiated were able to reject 
the transplanted tumours. The induced immunosuppression was also transferable by 
lymphocytes from irradiated mice (unable to reject the tumours) injected into non irradiated 
mice. It is known that UVR-induced immunosuppression is a complex process (Figure 1). 
UVR action spectrum for induction of CPDs is now known to be identical to that of Tumour 
necrosis factor alpha which in turn is induced by Interleukin-1. Direct immunosuppression 
locally in the skin comes about when UVB directly impacts on Langerhans cells. LCs: 
dendritic cells critical for the presention of antigens to the immune system, very sensitive 
even to UVR minimal dose. In a series of human experiments, solar simulated radiation 
whether, given as a single minimal erythema dose, or over ten times the time period, but 
with irradiance at 10% of the dose, or over 10 days at one tenth of MED, the outcome was 
the same: LCs numbers were depleted (Figure 1). The ability to do this appears to be genetic, 
and, in those individuals who fail to deplete LCs when initially exposed to antigen in the 
setting of UV exposure, PLE occurs. This ability to resist UV-induced depletion appears to 
be protective against skin cancer development. This hypothesis is supported by an 
epidemiological study of the prevalence of polymorphic light eruption in those who have 
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skin cancer, despite apparently equivalent UVR exposure, the prevalence of PLE appeared 
reduced (Lembo et al., 2008). Kripke’s experiments in mice suggest that SCCs are highly 
antigenic, thus mechanisms whereby antigen is recognised are relevant in the process of 
preventing UVR initiated skin cancers (Timares et al., 2008). Mutated cells carrying highly 
relevant p53 mutations are well described. Such clones of mutated cells are found in 
chronically UVR exposed skin. If the immune system is functioning, such mutant cells may 
be policed by antigen presenting cells and T memory cells and progression to skin cancers 
can be stopped. CPD are linked with the suppression of T memory cells thus UVR reduces 
immune surveillance by this mechanism. Therefore when immune regulation is perturbed, 
such as with ongoing sun-exposure, chronic lymphatic leukaemia or with long term 
systemic immuno-suppression, failure of immune regulation leads to progression of these 
clones to actinic keratoses and frankly invasive squamous cell carcinomas. Nucleotide 
excision repair is a very important protective response against skin cancer. Pyrimidine 
dimer formation in DNA initiates the tanning response in UV-irradiated mice. DNA repair 
results in fragments of DNA being excised from the DNA molecule, these tiny oligomers 
have been shown to directly cause immunoprotective effects when applied to the skin (Arad 
et al., 2006). A further UVR immunosuppressive effect is the isomerisation of a chemical 
component of the stratum corneum.: urocanic acid normally exists in its trans-isoform but 
with irradiation by UVB is transformed to its cis-isomer which is a powerful systemic 
immunosuppressant (Figure 1). The action spectrum for the induction of this process 
appears to be in the UVB range. There is evidence to suggest that cis-urocanic acid’s ability 
to suppress contact hypersensitivity is mediated via TNF-α (McLoone et al., 2005). UV-
irradiated urocanic acid is also able to suppress delayed hypersensitivity reactions to herpes 
simplex in mice (Ross et al., 1986). The complexity of UV-induced immunosuppression is 
compounded by the ability of UVR to modulate four main families of growth factors: 
epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor (PDGFR), 
fibroblast growth factor receptor (FGFR), and insulin receptor (IR), and in addition primary 
cytokines each of which has immunosuppressive effects. Apart from TNF-α, the interleukin 
family have wide ranging effects often interdependent. UV induces IL-1, IL-6, IL-10 amongst 
others. IL-10 is considered very important as a mediator of systemic immunosuppression 
(Ghoreihi & Dutz, 2006): tolerance induction by immunisation through UVR irradiated skin 
is transferable through CD4+CD25+ T regulatory cells and is dependant on IL-10 produced 
by the host. The mechanisms underlying UVR-induced tolerance therefore are complex and 
constantly being refined. UVR also induces platelet-derived growth factor (PDGF) thought 
to be pivotal both in UVB-induced immunosuppression and also the immunosuppression 
induced by PUVA. UVB activates receptors for the primary cytokines interleukin-1 and 
tumor necrosis factor-α and the death receptor Fas. UV also induces melanin stimulating 
hormone (MSH) locally, from keratinocytes; such paracrine secretion plays a critical role in 
local cell regulation from an immunosuppressive and proinflammatory point of view. The 
receptor for pigment regulation within melanocytes: melanocortin receptor (MCR) is also 
regulated by UVR (Figure 1). While increasing doses of UVB were found to cause increasing 
levels of immunosuppression, only a narrow range of UVA or solar-simulated UV 
suppressed the immune system. Doses of about 1.8 J/cm2 solar-simulated UV (0.5 
minimum erythema dose [MED]) delivered for three consecutive days, but not twice this 
dose-suppressed immunity to an antigen delivered to un-irradiated skin (induction of 
systemic immunosuppression). The UVA component of this, 1.68 J/cm2, was also 
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immunosuppressive, but twice this dose was not. It appears that while this low dose of 
UVA damages the immune system, higher doses can actually protect the immune system 
from UVB effects . UVA has also been reported to be as effective as solar-simulated UV at 
suppressing the reactivation of secondary immunity in mice (Moyal & Fourtanier, 2001). It, 
therefore, appears that different doses of UVA can affect immunity in quite different ways, 
presumably because UVA has complex dose effects on unknown molecular events. Doses of 
UVA within the range used some studies have been shown to produce ROS in human skin, 
and these ROS can be inhibited with reactive oxygen quenchers (Ou-Yanh, 2004). As 
increasing doses of UVA cause higher levels of ROS in the skin. It is likely that ROS are 
involved in UVA-induced immunosuppression. High dose UVA, which reverses UVB-
induced immunosuppression has been shown to mediate this effect via production of the 
antioxidant heme oxygenase enzyme. Thus, it seems probable that low doses of UVA initiate 
ROS production, which suppress skin immunity. In contrast, higher does of UVA stimulate 
production of protective antioxidant enzymes, thus reversing the suppressive effects of ROS 
and UVB. There has been some experimentation that supports the above hypothesis that 
UVA causes immunosuppression via a ROS-dependent mechanism, but considerably more 
work is required to definitively answer this issue and determine the steps involved. Other 
mediators may also be involved in UVA modulation of immunity, such as PGE2. It has been 
suggested that a cascade of events, initiated by UV-induced PGE2 production in the skin, in 
turn induces production of IL-4 and IL-10, which cause systemic immunosuppression 
(Figure 1). As increase PGE2 is a downstream event of lipids oxidative damage, the 
important role of UV-induced oxidative damage in photoimmunosuppression is 
highlighted. PGE2 has also been implicated in immunosuppression during chemical 
carcinogenesis in the skin (Andrews et al., 1991). More recently it has been shown that 
oxidized lipids, such as phosphatidylcholine, are recognized by the platelet activating factor 
receptor able to trigger immunosuppression (Walterscheid et al., 2002). The practical and 
visible consequences of these immunological perturbations are those of carcinogenesis, 
photoallergic reactions and infections.  Latent viral infection can be triggered or enhanced 
by UVR. The action spectrum for induction or activation of Herpes Simplex and/or 
Varicella Zoster virus seems to be in the UVB range. A new viral infection linked with UVR 
is the recently described Merkel cell polyoma virus (Paulson et al., 2009) and Human 
papilloma virus (HPV). HPV is ubiquitous in human skin, it is thought that the skin is 
colonised shortly after birth. More than 100 different virus subtypes are described and 
divided into mucosal and non-mucosal types. Different subtypes are associated with 
different clinical pictures. Up to recently, it was assumed that cutaneous sub-types did not 
interfere with apoptosis, as is the case for high risk subtypes, in which the E6 protein 
functions as a block in the apoptotic pathway interfering with the tumour suppressor gene 
p53. The consequence for those carrying high risk mucosal HPV may be anogenital 
squamous cell carcinoma. The role of human papilloma virus in carcinogenesis is well 
established in cervical cancer, in which persistent carriage of high risk viral types 16, 18, 31 
and 33 are incontrovertibly implicated in cancer pathogenesis. In keratinised skin, until 
recently, the story was less clear other than in the rare syndrome epidermodysplasia 
verruciformis (EV), where medium risk oncogenic type 5, 7 and 12 HPV interact with UVR 
to induce cancer. High risk HPV types 16 and 18 on keratinised skin are found rarely in 
periungual warts. Something important is supposed to occur in transitional areas: 
keratinised skin-mucosal epithelium or keratinised skin-nail. HPV favours anogenital areas, 
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lips nose and also UV-irradiated skin. Plane warts are almost inevitably found on the 
dorsum of the hands and the face, sites of maximal UV dose. Immunosuppression caused 
by UVR in irradiated areas leads to skin exquisitely suited to the proliferation of HPV; 
with the defences down, immune surveillance at a minimum, it is no surprise therefore 
that warts or dysplastic lesions, depending on HPV type, will flourish in these 
circumstances (O’ Connor, 2001). Recently mechanistic evidence has emerged implicating 
medium risk HPV in the aetiology of non-melanoma skin cancer, particularly squamous 
cell carcinomas, specially in immunosuppressed individuals. Mutated cells normally are 
shifted to the apoptotic pathway, but HPV has the ability to abrogate the proapoptotic 
BAK signalling via the E6 protein, leading to damaged cell survival (Leverrier et al., 2007). 
One of the difficulties when discussing immunosuppression is the absence of a good and 
standardized measure of immunosuppression. Most studies have measured effects of 
UVR on abrogating delayed hypersensitivity responses. In the context of contact 
dermatitis the immunosuppression-immunosurveillance state can be clinically evident 
through patch testing before and after UVR exposure. There is no good marker which 
reliably determines immunosuppression: the only epidemiological marker is circulating 
CD4 count. 
 
 
 
Fig. 1. UV-induced immunosuppression. 
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3. Photosensitive disorders 
Photosensitive disorders occur when human skin reacts abnormally to UVR or visible light 
(Murphy et al., 2001). Normal human skin produces a range of responses designed to 
protect man from adverse effects of UVR. The normal response is determined by skin colour, 
which is in part genetically determined, and skin thickness, which is influenced by adaptive 
responses to UVR (Murphy et al., 1991). The presence, extent and thickness of hair 
determine photoprotection. Age, pigment adaptation, body site and also antiinflammatory 
agents influence responsiveness to UVR. Classification of the photodermatoses traditionally 
is based on the cause of the disorder, where known, and on the pathology of cutaneous 
response (Table 1). Observation of the clinical patterns of skin reactivity and the timing of 
the response helps the investigator to classify disorders as many photodermatoses are of 
unknown cause. Photosensitive disorders may be broadly classified as primarily UVR 
induced such disorders include the idiopathic (some of which may perhaps now be better 
described as autoimmune) photodermatoses: Polymorphic light eruption, Juvenile spring 
eruption, Actinic prurigo (AP), Solar urticaria (SU), Hydroa vacciniforme, Chronic actinic 
dermatitis (CAD), Brachioradial pruritus, Actinic folliculitis. Phototoxic diseases are caused 
by external agents either systemic, or topically applied, which predictably lower the 
threshold for abnormal UVR responses. Photoallergic disorders occur idiosyncratically and 
may not be predicted, they are less common than phototoxic reactions and are determined 
by either delayed hypersensitivity responses or, more rarely, immediate hypersensitive 
reactions IgE mediated. Diseases that are characteristically photosensitive, but with other 
manifestations, include: xeroderma pigmentosum (XP), trichothiodystrophy (TTD), the 
Rothmund–Thompson syndrome and the cutaneous porphyries. Photoaggravated diseases 
are numerous: Lupus erythematosus (LE), Dermatomyositis, Psoriasis, Rosacea, Lichen 
Planus, Autoimmune bullous disease; these disorders occur independently of 
environmental UVR exposure, but may be worsened by exposure to UV. History and 
physical examination are most important aspects in the diagnosis of the photodermatoses. 
Most photodermatoses are manifest by cutaneous response to the sun at a lower dose to that 
which might be expected. The responses may be summarized either as inappropriate 
redness of the skin occurring immediately or as a delayed response. Immediate erythema 
occurring minutes after UVR exposure may be caused by SU, drugs, chemicals such as tar or 
creosote. Erythropoietic protoporphyria or rarely porphyria cutanea tarda may exhibit  
immediate erythema and urticaria, these latter responses are observed during formal testing 
with UVR and visible light more than with ambient daylight. Immediate erythema may, 
rarely be caused by contact allergens such as sunscreens. The morphology of responses is 
very variable and polymorphic: maculopapular eruptions occurring after UV are, most 
frequently, expression of PLE. However, similar reactions may also occur with LE, AP, 
erythema multiforme and drug eruptions. Urticaria case occurs in response to UV in SU, 
rarely as a response to drugs and in case of porphyria (erythropoietic protopophyria (EPP). 
Eczema, as a late reaction to UVR, occurs in CAD, in photosensitive atopic eczema  and in 
AIDS where patients at a young age may develop photosensitive eczema (Wong & Khoo, 
2003). In drug-induced photosensitivity, eczema also may be the consequence of agents such 
as thiazides. Lichenoid responses also may occur in response to many drugs including 
thiazides (Johnston, 2002). Bullous reaction to UVR and visible light can represent the clinical  
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picture of Hydroa vacciniforme (HV), a rare childhood disorder, mainly induced by UVA. 
Umbilicated blisters occur on the face and other exposed areas. Blistering, most frequently 
on the backs of the hands, can be seen also in cutaneous porphyrias. Drugs such as 
frusemide, nalidixic acid and amino-quinolones do not infrequently produce blistering in 
sunlight. Pseudo-porphyria is also recognized as a reaction to numerous agents. This 
disorder may occur not only with drugs, but also to sunbed over-exposure, and in those 
who sunbathe excessively with poor sun protection, with excessive UVA exposure. 
Endogenous porphyrins may be the relevant chromophore in the absence of a relevant drug 
(Murphy, 1989).  Telangiectasia may be the endpoint of photosensitivity in some situations. 
ACE inhibitors lead to photodistributed telangiectasia in patients, especially in renal 
transplant patients. Phototoxic burning represents an immediate discomfort of the skin on 
exposure to UVR or visible light in the absence of visible signs. This may also occur with 
drugs, topical agents such as tar or porphyria, especially in patient attended with EPP, or in 
treatment with photodynamic therapy (PDT) using amino-laevulinic acid or its esters that 
are metabolized to protoporphyrin IX. Phototoxic burning with PDT is particularly a 
problem with renal transplant patients where interactions may occur with the many 
photoactive drugs being taken. Hyperpigmentation also occurs as a response to 
photosensitivity, this may represent post-inflammatory hyperpigmentation, or interaction of 
UV/visible light with hormonally induced pigmentation as in melasma. In dark skin, 
photosensitivity may be primarily observable as hyperpigmentation. All dermatologists will 
be aware of the ability of PUVA to pigment skin. Lichen planus may be photoaggravated; 
clinically this may look like hyperpigmentation, but histology shows a lichenoid infiltrate. 
Hypopigmentation may be seen in CAD, and this seems to be post-inflammatory 
hypopigmentation. In some patients, as post-inflammatory reaction because of the Koebner 
phenomenon, vitiligo occurs. Vitiligo is made worse by sun exposure in some patients. 
Prurigo lesions, in the absence of obvious primary lesions are seen in AP, excoriations are 
maximally seen in UV-exposed areas but sun-protected sites also may be affected possibly 
as autosensitization. Photo-onycholysis may occur as an idiopathic phenomenon, but may be 
caused by some drugs, particularly tetracyclines, psoralens or it may occur in porphyria. It 
is infrequent because of the protective nature of the nail itself: thick keratin is very 
photoprotective. Photorecall reactions may also occur. Perhaps, 5-fluorouracil given 
systemically is the most frequent cause of this reaction. Patients undergoing chemotherapy 
with this agent may develop florid redness and burning and even erosion of photodamaged 
skin even though they may not have been outdoors for weeks. Presumably the reaction is 
similar to that of topical Efudix that selectively kills cells with the most UV-induced 
damage. Pruritus may be the sole manifestation of photosensitivity. Immediate pruritus 
suggests SU, and it rarely occurs in the absence of erythema and urticaria. Pruritus occurring 
within hours with the same time course as PLE has been described sine eruptione. Itching 
can occur 1–2 weeks after sunburn probably representing the reaction of sensitive skin to 
desquamation, soothed by emollients. Dysaesthesia occurring after intense UV exposure may 
persist for weeks; threshold responses are normal, and brachioradial pruritus appears to be 
neuralgia secondary to UVR damage to the skin. Many disorders develop photoadaptation; 
thus, the patient and clinician may be misled by the fact that the face is unaffected, but sites 
only occasionally exposed to the sun are worst affected. Photodermatoses may occasionally 
be highly localized and the nature of the disorder can be elucidated only by testing. Formal 
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testing is essential to make a definite diagnosis of CAD. In the absence of abnormal tests, the 
diagnosis cannot be made. Most patients have abnormal threshold responses to UVR with 
the same action spectrum as the human erythema spectrum, suggesting that the 
chromophore for CAD is DNA. A minority of patients exhibit UVA photosensitivity, but 
this is more commonly the pattern of drug-induced photosensitivity and thus drugs should 
be excluded in such cases. PLE and juvenile spring eruption usually exhibit normal light 
tests; 30% of PLE patients demonstrate abnormal responses, either to UVB, UVA or both, 
and very rarely PLE may be induced by visible light. AP is more often UVA-induced with 
about 70% of patients showing abnormal reactions. HV is also usually UVA sensitive. SU 
patients usually produce immediate responses with erythema and urticaria to the eliciting 
wavelengths. The action spectrum of SU is usually UVA, often UVB and visible light. In 
individual patients, the action spectrum may broaden, and in some patients, the disorder 
may spontaneously clear (Beattie, 2001). A solar simulator is a xenon arc lamp fitted with 
filters such that the output of the lamp reproduces terrestrial sunlight. The intensity of the 
lamp is much higher so photodermatoses may be reproduced in the laboratory, confirming 
diagnosis and proving photosensitivity if a patient has normal monochromator tests. 
Depending on the population tested, 100% of patients with CAD have abnormal responses. 
Seventy per cent of patients with PLE have reproducible PLE as do AP and HV. SU is almost 
always reproduced, but occasional patients only react to natural sunlight. Different 
schedules are used to provoke photodermatoses (van de Pas et al., 2004). Large areas of 4x4 
cm2 or more, need to be used, on body sites where the rash normally occurs. Thirty per cent 
of patients react with one exposure, repeating the irradiation twice more increases the yield 
to 70%. This is useful to prove a rash is UV-induced in the absence of other pointers. All 
patients with exposed surface eczema should be patch and photopatch tested. Photoallergic 
contact dermatitis is uncommon (Darvay et al., 2001). Review of the relevant allergens for 
photopatch testing shows that virtually all positive photopatch tests in recent years are 
because of sunscreen ingredients. Previous photoallergens such as 6-methyl coumarin, musk 
ambrette and related molecules have been discontinued by the perfume industry in Europe 
because of previous relatively frequent sensitization. Tetrachlorosalicylanilide also is no 
longer encountered; thus, it is no longer relevant to test with these agents. Testing perfume 
ingredients,  plant materials and drugs such as promethazine, chlorpromazine and non 
steroidal anti-inflammatory drugs leads to such a number of false-positive phototoxic 
reactions that it is better to omit these agents. In the rare true allergic reaction it is important 
to use a low concentration of the allergen and administer no more than 5 J/cm2 UVA or 
even 1–2 J/cm2. The crescendo pattern of test reaction, with most intense picture observed 
the second reading, compared with the first, distinguishes allergy from phototoxic reactions 
that fade after the time of the first reading. Some patients may need testing to their own 
products, but if a new agent is being assessed, it  is essential to test a control panel of 20 
subjects to this agent to exclude false-positive results. Investigation of the photodermatoses 
offers a considerable amount of information not otherwise available. Some patients are 
surprisingly photosensitive when formally tested. Clinical impressions may be completely 
overturned. Formal testing conclusively proves the diagnosis of photosensitivity if the tests 
are abnormal. Photosensitive individuals may, however, have normal light tests. 
Photoprovocation using a solar simulator is helpful to demonstrate that the disorder is UV-
induced. 
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Idiopathic 
photodermatoses 
Photoallergic contact 
dermatitis/photoxic 
contact sensitivity 
Drug induced 
(photoxic/photoallergic)
Genophotodermatoses 
Photoaggravated 
disease 
Disease aggravated  
or precipitated by 
UVR-induced 
immunosuppression 
Polymorphic light 
eruption 
Antibiotics 
Xeroderma  
pigmentosum 
Lupus 
erythematosus 
Herpes simplex 
infection 
Juvenile spring 
eruption 
Diuretics Trichothiodystrophy Dermatomyositis Viral exanthemata 
Actinic prurigo Antipsychotics Bloom’s syndrome Eczema Plane wart 
Solar urticaria Sedatives Cutaneous porphyries Psoriasis Skin cancers 
Hydroa  
vacciniforme 
Antihypertensive  
agents 
Kindler-Weary  
syndrome 
Rosacea  
Chronic actinic 
dermatitis 
Non-steroid anti-
inflammatory drugs 
Smith-Lemli-Opitz 
syndrome 
Lichen planus  
Brachioradial 
pruritus 
Antidiabetic-agents  
Autoimmune 
bullous diseases
 
Actinic folliculitis Lipid-lowering agents  Vitiligo  
 Protease inhibitors  
Vitamin B6, 
niacin deficiency
 
Table 1. Classification of photodermatoses 
3.1 Polymorphous light eruption 
Polymorphic light eruption (PLE) is the most common of the idiopathic photodermatoses. It 
is an acquired disorder characterized by an intermittent, transient, delayed response, 30 
minutes to several hours after UV light exposure. The cutaneous response has been 
described as nonscarring, pruritic, erythematous papules, vesicles, or plaques on light-
exposed skin. Other presentations include vesiculobullous, hemorrhagic, erythema 
multiforme-like, and strophulus-like (insect bite) appearances. In the absence of additional 
UV exposure, the eruptions resolve in hours to as long as 2 weeks, leaving completely 
normal skin. PLE is the most common photosensitivity. It affects females two to three times 
more often than males and onset is typically in the first three decades of life. The incidence 
is estimated at 10% in the United States, 21% in Sweden, 15% in the United Kingdom, and 
5% in Australia. All racial skin types have been documented as being affected in the medical 
literature, however, it most commonly occurs in fair-skinned individuals of Fitzpatrick skin 
types I–IV. PLE has been widely reported, but it occurs most frequently in temperate 
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climates and is least prevalent in subtropical and tropical areas. Episodes of PLE usually 
occur in the spring and occasionally in the fall. Patients are usually less susceptible during 
the summer and winter. This prevalence during the spring and fall, as well as the 
predilection for temperate climates, may be explained by the greater proportion of UVA to 
UVB light in these settings. It is possible that the higher proportion of UVB to UVA during 
the summer months may inadvertently reduce UVA exposure because of earlier sunburning 
and, therefore, reduce susceptibility through a UVB-induced alteration in immunologic 
reactivity. Although classified as an acquired idiopathic photodermatoses, familial 
clustering is suggestive of a genetic etiology. A recent study examined 119 monozygotic 
twin pairs and 301 dizygotic twin pairs, revealing an incidence of 21% among the 
monozygotic twins and 18% in dizygotic twins. The study also demonstrated that PLE was 
present in one or more first-degree relatives (excluding the co-twin) in 12% of affected twin 
pairs compared with 4% of relatives in unaffected twin pairs, thus providing statistically 
significant evidence of familial clustering (p< 0.0001) (Milliard et al., 2000). Ultimately a 
combination of genetic and environmental factors is probably responsible for expression of 
PLE. PLE has been considered, for long as a possible, delayed-type hypersensitivity (DTH) 
response to an endogenous, cutaneous UV-induced antigen, because of the hours or days 
delay between sun exposure and manifestation of symptoms, and the histological 
appearance of lesional skin. Firm evidence, however, has been lacking and the responsible 
allergen has not been identified. UV irradiation may convert a potential precursor in the 
skin to an antigen that causes a DTH reaction, resulting in the clinical appearance of the 
disease. The nature of this hypothetical precursor or antigen, however, remains obscure. 
More recently, timed biopsies following irradiation with artificial light sources, with doses 
below the MED, have shown perivascular infiltrates of mainly CD41 T lymphocytes within a 
few hours and CD81 cells within days; an increased number of dermal and epidermal 
Langerhans cells and dermal macrophages has also been observed, suggesting the DTH 
pattern seen in allergic contact dermatitis and the tuberculin reactions. In addition, E-
selectin, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 
(ICAM-1), identified on keratinocytes above areas of dermal leukocyte infiltration, are also 
expressed as in other DTH responses. UV-induced immunosuppression is a consistent 
finding in normal skin and it was hypothesized that this process may protect the skin from 
UV-induced photoallergens. Thus, susceptibility of individuals to PLE could arise from a 
failure of normal UV-induced immunosuppression. Kolgen et al. reported that the skin of 
PLE patients was less susceptible to UVB-induced migration of CD11 Langerhans cells. 
Following a six MED dose of UVB, there was a significant failure of LC to migrate from the 
epidermis of PLE as compared with normal subjects. They also found a significant reduction 
in UVB-induced infiltration by CD11b1 macrophage-like cells in PLE compared with 
healthy skin, which was considered to represent an important finding in view of the 
prominent role of these cells in the secretion of the immunosuppressive cytokine IL-10. It 
was thus postulated that the pathologic defect underlying PLE might be a failure of normal 
photoimmunosuppression. If this is the case, the balance of UV-induced suppression and 
UV-induced provocation would be altered, allowing sunlight exposure to provoke PLE 
eruption. More recently, Kolgen et al. assessed whether there are abnormalities of UV-
induced secretion of  TNF-α and interleukin-1b, cytokines known to be important in 
affecting LC migration. Secondly, they examined the effects of UV on secretion of T-helper 
cell type 2 (TH2) cytokines IL-4 and IL-10, which mediate immunosuppression. They 
concluded that the reduced expression of  TNF-α, IL-4, and IL-10 in the UVB irradiated skin 
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of patients with PLE appears largely attributable to a lack of neutrophils and it is indicative 
of reduced Langerhans cell migration and reduced TH2 skewing. Impairment of these 
mechanisms essential for UVB-induced immunosuppression may be important in the 
pathogenesis of PLE (Kolgen, 2004). Palmer and Friedmann performed functional studies 
examining DTH responses in PLE and concluded that induction of sensitization by 2,4-
dinitrochlorobenzene (DNCB) is less suppressed by UV in patients with PLE compared with 
healthy controls. Beyond this, van de Pas et al. recently showed a reduction in UV-induced 
suppression of DTH response to DNCB in PLE, such that these patients are less easily 
sensitized to DNCB than in healthy subjects. Also Schornagel et al. suggested a role for 
neutrophils in the pathogenesis of PLE, by showing a relative reduction in UVB-induced 
infiltration with neutrophils. It is conceivable that abnormalities in both neutrophil and 
mononuclear cell activity could be implicated in the pathogenesis of PLE. However, the 
most recent findings on the effect of solar-simulated radiation on the elicitation phase of 
contact hypersensitivity revealed no significant difference between controls and patients 
with PLE. These results contrasted with previous findings of the same group that had 
indicated a resistance to UV-induced suppression of sensitization to DNCB in PLE. This 
difference may reflect the greater importance of Langerhans cells in the sensitization phase, 
and is consistent with the hypothesis that PLE arises from impaired suppression of 
Langerhans cell activation or migration (Palmer, 2005). The reason for the occurrence of PLE 
appears likely to be genetic with a significant environmental component, with 70% of the 
population perhaps having a tendency to the condition but not all expressing it because of 
poor penetrance. However, the culprit gene has not been identified yet. This genetically 
determined factor, which leads to the putative immune recognition of an autologous 
cutaneous antigen generated by UV radiation in PLE, but not normal subjects, although the 
antigen is presumably expressed in all individuals. The inducing UV absorbers and antigens 
in PLE have not been characterized; tough has been suggested a form of heatshock protein. 
A variety of such antigens within and between patients, however, seems more likely. In 
addition, the induction of lesions by a UVA sun bed in the non-tanning sacral pressure area 
further suggests that the UV–chromophore interaction in at least some patients may be 
oxygen independent. Determination of the action spectrum of PLE by experimental 
reproduction of skin lesions using artificial radiation sources has led to conflicting results. A 
lack of response, often to adequate doses of artificially produced UV radiation, by patients 
who react readily to just suberythemogenic doses of natural sunlight may be attributed to a 
number of variables. These include the size of the UV irradiation site and its location, the 
irradiation of small, normally unaffected areas perhaps not eliciting sufficient immunologic 
stimulus to activate the response, but also to the UV spectrum, irradiation dose, dose rate, 
and degree of cutaneous immunologic tolerance, which may be increased by any recent 
prior exposure. Moreover,  there is a lack of universally accepted, standardized phototest 
protocols under revision of board of experts. The complex interrelationships between factors 
such as these, have clearly contributed significantly to the conflicting nature of reports 
concerning the most effective wavelengths for PLE induction. In most series, UVA has been 
more effective than UVB. Thus, in one of these studies, following exposures of buttock skin 
to UVA or UVB daily for 4–8 days, the action spectrum was in the UVA range in 56%, UVB 
in 17%, and both in 27%. In another study 68% of reaction were triggered by UVA, 8% by 
UVB, and 10% by both wavelengths. This apparent diversity in action spectrum of PLE is 
possibly the result of different UV-provoked inducing antigens, and perhaps also of 
different cutaneous levels for these antigens. Variation in the proportions of UVA and UVB 
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present in terrestrial sunlight may also explain certain clinical characteristics of PLE. Thus, 
the greater proportion of UVA to UVB in temperate climate zones, and during the spring 
and fall months, might be expected to contribute to a higher incidence of PLE in temperate, 
rather than tropical regions, with greater susceptibility to the condition in spring and 
occasionally autumn, rather than summer in most patients. Moreover, the higher proportion 
of UVB to UVA in summer sunlight also probably inhibits PLE development through a 
predominantly UVB-induced cutaneous immunosuppressive mechanism. Older generation 
sunscreens without substantial UVA protection, encouraged to stay much longer in the sun, 
thereby receiving a much higher UVA dose than without UVB protection, did not provide 
adequate protection against provocation of PLE. Clinical features of PLE are characterized 
by lesions that, generally, develop symmetrically and affect only some sun-exposed areas of 
the skin, often those that are normally covered in winter, such as the V area of the chest, the 
external aspects of the arms and forearms and lower anterior aspect of the neck. 
Occasionally, the face can be involved. Symptoms are worse in spring and early summer. 
The eruption typically begins each spring or early summer, on sunny vacations, or after 
recreational tanning use, often moderating with continuing exposure. Also outdoor 
activities in winter may induce the rash, and it may also occur by exposure through window 
glass (Hampton, 2004), which is penetrated by UVA such as light cotton clothing. The 
eruption develops after minutes to hours or sometimes days of sun exposure and lasts for 
one to several days or occasionally weeks, particularly with continuing exposure. Skin 
eruption, however, often fades or ceases as summer or the vacation proceeds (‘hardening 
process’). A PLE severity index (PLESI) has been proposed to produce a simple, valid, and 
reproducible method to assess the severity of the disease (Palmer, 2004). In the absence of 
further exposure, lesions gradually subside completely, without scarring over a few days, 
occasionally over a week or two. In a given patient, the eruption tends always to affect the 
same skin sites. Associated systemic symptoms are quite rare: chills, headache, fever, and 
nausea have been reported but may have been the consequence of accompanying 
sunburn.This condition may last life-long but gradually improves over years in many 
patients: over 7 years, 64 of a series of 114 patients (57%) reported steadily diminishing sun 
sensitivity, including 12 (11%) that totally cleared. PLE has many morphologic variants, as 
indicated by the name. Lesions vary widely between patients, but are generally pruritic, 
grouped, erythematous or skin-colored papules of varying size, not infrequently coalescing 
into large, smooth or rough-surfaced plaques, sometimes resembling subacute cutaneous 
lupus erythematosus. Vesicles, bullae, and papulovesicles, as well as confluent edematous 
swelling (particularly of the face), are also possible, while rarely erythema or pruritus alone 
(PLE sine eruptione) may occur. Insect bite-like, and erythema multiforme-like variants 
have also been described. A particular variant in African Americans occurs as ‘pinpoint’ 
variant. In addition, the helices of the ears may be primarily affected often with vesicles, 
particularly in boys. This form of PLE was previously termed ‘juvenile spring eruption’. The 
papular form, of either large or small separate or confluent lesions, generally tending to be 
in clusters, is the most common, followed by the papulovesicular and plaque variants; the 
others are rare. The eczematous form probably does not exist, representing rather chronic 
actinic dermatitis instead. A final morphologic variant, a small papular form generally 
sparing the face and occurring after several days of exposure on vacations has been 
designated as benign summer light eruption in Europe. Hematoxylin and eosin staining of 
PLE reveals superficial and deep dermal inflammatory cell infiltrate. While the infiltrate is 
predominantly perivascular, there is sometimes a heavy interstitial infiltrate of lymphocytes 
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in the upper dermis, in those variants characterized by prominent subepidermal edema. The 
upper dermis frequently exhibits edema, particularly in plaque-like lesions. Epidermal 
changes, if present, are variable and range from mild spongiosis to acanthosis. A study 
performed to explore the immunohistopathology of photoinduced cutaneous lesions in LE 
patients revealed some important differences between these lesions and the cutaneous 
lesions seen in PLE patients. Of 22 person enrolled in this study, 16 patients had LE and 6 
PLE. The study explored both cellular infiltrate and deposition of immunoreactants in the 
epidermis and dermis of lesions. The biopsies that were taken from two patient groups were 
examined for multiple classes of cellular infiltrates using standardized markers. The 
biopsies were screened for CD3+, CD4+, CD8+, M718+, CD15+, CD1+, CD22+ cells, and 
lue7 cellular marker. Specific attention was paid to the perivascular and dermoepidermal 
interface. Summation of the cellular populations from these samples revealed two 
significant differences. The first observation noted was the high prevalence of M718 cells at 
the dermoepidermal interface in LE patients, suggestive of active migration of M718+ 
monocytes toward the epidermis. The other significant difference was the increased CD1+ 
cell population seen throughout the entire dermis of PLE patients. The findings seen in the 
biopsies agree with past studies conducted on PLE patients. Current data suggests that this 
increased population of CD1+ cells represents the epidermal Langerhans cell population 
that is migrating toward the area’s lymph nodes to present their antigen and elicit a type IV 
immune reaction. To examine if there were any significant findings related to 
immunoreactant deposition, the biopsies were tested for IgA, IgG, IgM, and C3c at the basal 
membrane zone. Results from past studies have revealed little or no presence of 
immunoglobulin at the basal membrane zone in patients with PLE. In summary, these 
results did not allow any positive significant conclusions to be drawn about diagnostic 
significance or pathologic etiology of PLE related to LE. Microscopic analysis of skin tissue 
is mostly not necessary, but can be helpful where there is diagnostic difficulty. The 
diagnosis of PLE is made principally on clinical grounds based on the typical morphology of 
the eruption. Although the diagnosis is mainly clinical, provocative phototesting may be 
valuable in winter if no lesions are present, to confirm the diagnosis. The best way to do this 
is by using repetitive irradiations on the V area of the neck or forearms for 1-4 consecutive 
days. This can be done with high-intensity monochromatic UVA and UVB sources or with a 
solar simulator. The doses needed are not necessarily erythemal. Readings are made 
immediately and up to 72 h after the last irradiation. As mentioned above, abnormal 
reactions can be provoked in more than 60% of patients. In most studies more patients 
reacted to UVA than to UVB. In case of positive UVA or UVB test, the reaction does not 
necessarly correlate to PLE clinical features and not significant relationship with clinical 
disease severity has been showed (Janssens et al., 2007). There are no diagnostic laboratory 
tests available for PLE. Laboratory examinations are usually performed to exclude other 
dermatoses, such as photosensitive lupus erythematosus or erythropoietic protoporphyria. 
Subacute cutaneous lupus erythematosus, which is generally not itchy as PLE, must be 
excluded in some patients by determining antinuclear, Ro (SSA) and La (SSB) antibody 
titers. Persistent plaque-type PLE must also be differentiated from Jessner–Kanof’s 
lymphocytic infiltration of the skin, while the photo-exacerbation of dermatoses such as 
atopic and seborrhoeic eczema may occur in susceptible subjects with the same time course 
as for PLE, but with differing and characteristic morphology. PLE treatment has to be 
subdivided into therapy for the acute exacerbation and prophylactic therapy before 
expected sun exposure. The mild disease of many patients is satisfactorily controlled by the 
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moderation of sun exposure at times of high UV intensity, use of protective clothing, and 
the regular application of broad-spectrum sunscreens with high-protection factors including 
UVA filters. A combination of sunscreens with antioxidants was reported to be more 
effective than sunscreen alone, but this awaits further confirmation (Patel et al., 2000). 
Patients with fully developed disease require topical corticosteroids, in some cases in the 
form of wet dressings, for several days. More severe attacks may be treated effectively with 
a short course of systemic (oral or injection) corticosteroids (Patel et al., 2000). Because PLE 
will subside spontaneously and is not a life-threatening condition, all possible risks of 
therapy should be carefully considered. Many patients will agree to undergo some sort of 
preventive measures. Prophylactic treatment consists of several approaches. The mildly 
affected majority of patients will prevent their PLE, to significant degree, by control or 
avoidance of sunlight exposure and by using a topical high-factor broad-spectrum 
sunscreen. For others, gradual sun exposure in spring effects browning and thickening of 
the skin (so called hardening), which often helps to avoid PLE. Severely affected subjects, 
suffering frequent attacks throughout the summer may require courses of prophylactic 
phototherapy or photochemotherapy in the early spring before the expected sun exposure. 
At a first glance it appears somewhat bizarre to use light treatment to prevent a condition 
that is caused by light, and the mechanisms by which UVB and PUVA induce tolerance to 
sunlight are not completely understood. Pigmentation and thickening of the stratum 
corneum may be important factors for the protective effect, and UVB, high-dose UVA, and 
PUVA are efficient triggers of both. Although these local effects may provide some barrier 
against photosensitivity, they probably do not suffice to explain the degree of protection 
induced in many patients. Thus, other mechanisms may be involved, as photodermatoses 
do occur in dark-skinned subjects (Kontos et al., 2002). It is therefore now generally accepted 
that UVA, UVB, and PUVA therapy exert a variety of immunomodulatory effects on human 
skin and that this is of critical importance for the therapeutic efficacy of phototherapy. 
Janssens et al.. showed that UVB hardening significantly normalizes UV-induced cell 
migratory responses of Langerhans cells and neutrophils in patients with PLE. PUVA is a 
very effective preventive treatment. In approximately 70% of patients with this condition, a 
3–4-week course of PUVA, 3 times a week, suffices to suppress the disease upon subsequent 
exposure to sunlight. The initial exposure and dose increments should be performed 
according to the guidelines outlined for psoriasis. PUVA induces pigmentation rapidly and 
intensively at relatively low suberythemogenic UVA doses that usually remain well below 
the threshold doses for eliciting PLE. About 10% of the patients develop typical lesions 
during the initial phase of PUVA. Interruption of treatment or reduction in the UVA dose is 
rarely required in such cases. Usually, brief symptomatic treatment with topical 
corticosteroids suffices. PUVA therapy protects only temporarily, and regularly repeated 
sun exposures are subsequently required to maintain protection. However, a considerable 
number of patients remain protected for 2–3 months, even after pigmentation has faded. The 
use of narrow-band 312 nm UVB phototherapy has become increasingly popular, being 
simpler to administer, perhaps safer than PUVA and of comparable efficacy. Also exposure 
of prophylactic UVB may sometimes trigger the eruption, particularly in severely affected 
subjects, necessitating occasionally concurrent systemic corticosteroid therapy. Commercial 
‘sun beds’ are not recommended because they are most likely to provoke PLE rash. Patients 
who only develop their disorder during infrequent vacations, also generally have good 
result from preventive oral corticosteroids course. Other therapies, that are quite often listed 
in textbooks, are of uncertain efficacy. Such remedies include antimalarials, long been 
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advocated, b-carotene, and nicotinamide, likewise probably only moderately effective are 0-
3 polyunsaturated fatty acids (Murphy et al., 1987) (38). The efficacy of Escherichia coli 
filtration (Colibiogen) awaits further confirmation. Also systemic antioxidants were unable 
in reducing the severity of the disease  (Eberlein-konig et al., 2000). The use of 
immunosuppressants should certainly be restricted to some rare severe disabling cases 
(Shipley, 2001). Recently, the photoprotective activity of oral polypodium leucotomos 
extract was shown to exert significant improvement in PLE patients (Caccialanza et al., 
2007). 
4. UV-induced skin cancers 
Lifestyle changes during the past five decades, with increased sunlight exposure because of 
outdoor activities and worsening sunbathing habits, often result in skin cancers (SCs). 
Among Caucasians, intense early sunburns and blistering sunburns are closely associated 
with the development of melanoma. As a result of chronic UV exposure: skin aging, 
wrinkles, uneven skin pigmentation, loss of skin elasticity and a disturbance of skin barrier 
functions are nowadays well recognized. These changes in the skin that superimpose the 
alterations of chronological aging refer to photoaging. The development of squamous cell 
carcinomas, SCCs and BCCs, and malignant melanoma is often associated with painful 
sunburns.  In fact, more than 1 severe sunburn in childhood is associated with a 2-fold 
increase in melanoma risk (Ma et al., 2007). Chronic exposure to UVR is known as the most 
important risk factor for the development of actinic keratoses (precursors of SCC). Exposure 
to UVR during childhood and adolescence plays a role in the future development of skin 
cancer. It was noted that in the US, most people receive 22.73% of their lifetime exposure to 
the sun by 18 years of age. This meant that during childhood (1–18 years of age), most 
people received approximately one-fifth of their total sun exposure. The total amount of sun 
received over the years, and overexposure resulting in sunburns are associated with skin 
cancers. The epidemiology implicating UV exposure as a cause of melanoma is further 
supported by biological evidence that damage caused by UVR, particularly damage to 
DNA, plays a central role in the development of melanoma. The relative risk of skin cancer 
is three times as high among people born in areas that receive high amounts of UVR than 
those who move to those areas in adulthood. Likewise, outdoor workers have a higher risk 
than indoor workers (Glanz et al., 2007). The aforementioned citations conclude that there is 
a dose-related relationship between sunlight exposure and the incidence of skin cancer. For 
the development of BCC and melanoma, intermittent intense exposures appear to carry a 
higher risk than lower level chronic exposures, even if the total UV dose is the same. By 
contrast, the risk for SCC is strongly associated with chronic UV exposure but not with 
intermittent exposure. Taken together, epidemiologic studies and experimental studies 
indicate that intermittent intense and chronic exposures to solar UVR are the primary cause 
of non melanoma skin cancer (NMSCs) and melanoma. Indeed photo-carcinogenesis plays a 
pivotal role in skin cancer occurrence in the general population and not only in high risk 
group such as patients affected by Gorlin’s syndrome or Xeroderma pigmentosum. Other 
agents, relevant in the past such as arsenic are now extremely rare as population exposure 
manly ceased in the 1960s. Ionizing radiation is an ongoing cause of skin cancer, but overall 
ultraviolet radiation accounts for more than 90% of skin cancers. Ultraviolet radiation is a 
complete carcinogen which means that, on its own, it has the ability to cause skin cancer 
without the need for other factors, although other co-carcinogens may have an expediting 
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effect on skin cancers leading to earlier onset or increasing SC number. Initiation of skin 
cancer comes about by DNA absorption of UVR, specific wavelengths which are similar to 
the ones able to induce erythema. Such absorbed photons lead to CPDs, which in case are 
not removed, they lead to errors in the transcribed DNA strand. The DNA repair 
mechanism is complex and comprises a series of enzymatically controlled steps whereby the 
DNA double helix is uncoiled, the cross-linked thymine dimer usually is repaired and DNA 
is reconstituted. DNA repair is an error–prone process and mutated genes may be retained. 
More than thirty different enzymatic steps contribute to the process of DNA repair 
involving nucleotide excision repair (NER), a specific response to the damage caused by 
absorption of UVR in human skin. Use of topically applied liposomal enzyme T4 
endonuclease V which specifically removes CPDs in a clinical trial on xeroderma 
pigmentosum led to fewer basal cell carcinomas and actinic keratoses indicating the 
relevance of these lesions to carcinogenesis. Aging skin is less efficient at removing CPDs; 
this together with the accumulation of UV-induced DNA damage augments carcinogenesis. 
Though UVB is most efficient at inducing CPDs, UVA also induces these lesions 
participating in the carcinogenic UVR effect. As defence mechanism, apoptosis should help 
prevent SC. Cells carrying too much in the way of damaged DNA for easy repair, or 
accurate NER, are instructed, by complex cell signalling pathways caspase mediated, to self 
distruct: the so called programmed cell death. Damaged cells escaping repair or apoptosis 
proliferate and skin cancer arise. The genome guardian p53 has a key role in this process. 
Ultraviolet radiation induces p53 and it leads to p21 synthesis, able to  stop the cell cycle in 
S1, enabling DNA repair to take place. MDM2 protein is also induced and serves as a 
mechanism for shutting off p53, and enabling its degradation via the ubiquitination 
pathway. The time course for these UVR-induced molecular events has been elucidated in 
vivo in human skin; further studies measured the time for apoptosis induction after 3 
repeated MED exposures. Later, in the time course of the sunburn response the protein Bax 
is induced which leads to apoptosis and safe elimination of damaged cells. Skin cancer is the 
most common type of cancer in light skinned populations around the world. Skin cancers 
are mainly divided into melanoma, and non-melanoma skin cancers (NMSCs), the latter 
including basal and squamous cell carcinomas. Melanoma is responsible for most of the 
cancer related mortalities, and NMSCs are typically described as having a more benign 
course with locally aggressive features. Nevertheless, they represent ‘‘the most common 
type’’ of cancer in humans and they can result in significant disfigurement, leading to 
adverse physical and psychological consequences (Suarez, 2007).  It is estimated that 2–3 
million cases of NMSCs occur worldwide each year. The incidence varies with very high 
rates in the Caucasian populations. For incidence, the overall upward trend observed in 
most parts of Europe, Canada, USA and Australia shows an average increase between 3% 
and 8% a year (Rhee et al., 2007). The incidence of NMSCs is over 1.3 million cases each year 
in the U.S.; in fact, this incidence rate is expected to double in the next 30 years (Rhee et al., 
2007). Approximately 30% of all newly diagnosed cancers in the U.S. are BCC, making it the 
most commonly diagnosed cancer in this country (Rittiè et al., 2007). BCC, which accounts 
for 80–85% of all NMSCs, rarely metastasizes to other organs. It is the most common 
malignancy in white people. Its worldwide incidence is increasing by up to 10% with 
highest rates in elderly men and increasing incidence in young women. Although mortality 
is low, this malignancy causes considerable morbidity and places a huge burden on 
worldwide healthcare systems. SCC, which accounts for 15–20% of all NMSCs, is more 
likely to invade other tissues and can cause death. As a result of the benign nature of NMSC 
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characteristics, some patients may remain unregistered and undiagnosed, leading to an 
under-representation of the number of cases. Moreover, as NMSCs have localized 
symptoms and primarily manifest in older individuals, they may remain undiagnosed. BCC 
and SCC are usually found in sun exposed areas, especially the head and neck regions. They 
are both positively related to the amount of UVR received and inversely proportional to the 
degree of skin pigmentation in the population. Women have higher occurrences than men 
for both types of cancers on the legs, consistent with greater sun exposure at this site. In 
2006, a study reported that the ratio of BCC to SCC is 4 : 1 for the head and neck (Gloster & 
Neal, 2006). The probability of getting SCC is less than getting BCC; however, SCC carries a 
> 10-fold higher risk of metastasis and mortality. It is estimated that 132,000 new cases of 
melanoma occur worldwide each year. Incidence rates are at least 16 times greater in 
Caucasians than African Americans and 10 times greater than Hispanics. The WHO also 
estimates that as many as 65,161 people a year worldwide die from malignant skin cancer, 
approximately 48,000 of whom are registered. Melanoma represents only about 3% of all 
skin cancers in the U.S., but it accounts for about 75% of all skin cancer deaths. The 
American Academy of Dermatology (AAD) in 2009, reported about 121,840 new melanoma 
cases in the U.S. with 8650 deaths (1 death every hour). This mortality value is remarkably 
high considering the fact that melanoma is nearly always curable in its early stages; 
however, this high number can be attributed to the late diagnosis of the disease in which the 
cancer spreads to other parts of the body. Over the last three decades, the incidence and 
mortality rates of melanoma have increased in the U.S. In particular, of all neoplasms, 
approximately 20–30% of skin cancers are diagnosed in Caucasians, 2–4% are in Asians and 
1–2% are in blacks and Asian Indians. In 2006, of all skin cancers, melanoma represented 1–
8% in blacks, 10–15% in Asian Indians and 19% in Japanese. Moreover, even though skin 
cancers are not as prevalent in individuals with darker skin, they can have more morbidity 
and fatalities as they may go undiagnosed for a while. Melanoma most often appears on the 
trunk of men and the lower legs of women, although it can be found on the head, neck, or 
elsewhere. As the incidence of skin cancer is increasing at an alarming rate, it is one of the 
greatest threats to public health.  
5. PLE and skin cancer: Is one protective against the other? 
For everything said so far, it would seem that the skin performs a ‘balancing act’ between 
adequate elimination of early cancerous cells and suppression of abnormal reactions against 
UV-exposed cells that may suffer transient aberrations. PLE appears to be associated with an 
‘imbalance’ between UV-induced proinflammatory and UV-induced suppressive 
immunoreaction. Supporting the link between susceptibility to UV-induced 
immunosuppression and PLE incidence is the fact that PLE patients demonstrate a 
functional resistance to UV-induced immunosuppression, favouring a DTH response to 
potential UV-induced neo-antigens under certain circumstances (Palmer, 2004). High UV 
radiation dose (2 MED) resulted highly immunosuppressive in both, PLE patients and 
controls, leading to almost complete immune suppression by 93%. This might explain why 
PLE lesions are often provoked by exposure to low doses of UV radiation but rarely by 
severe sunburn PLE patients MED values do not differ significantly from those of normal 
subjects, although in some study it results lower. Further studies are required to fully 
elucidate these pathways. Another aspect of PLE that requires further investigation is the 
disproportionate incidence observed in females compared with males. Notably, it has been 
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found that females are probably due to a more resistant to the immunosuppressive effects of 
UV radiation. Moreover, the results of a study by Widyarini et al. suggest that the sex 
difference in PLE may be due to protection from UV-induced immunosuppression afforded 
to females via signalling through the oestrogen receptor (Widyarini et al., 2006). Indeed, 
female hormone 17b-oestradiol may prevent UVR-induced suppression of the CHS response 
caused by the release of immunosuppressive cytokines (e.g. IL-10) from keratinocytes 
(Hiramoto et al., 2004). This might explain why PLE is more common in females than in 
males and why the risk decreases in women after the menopause. Because of these gender 
differences in UV-susceptibility together with the higher incidence of skin cancer in males, 
future studies must address the question of whether resistance to UV-induced 
immunosuppression lowers the skin cancer risk in PLE patients. Yoshikawa et al. compared 
normal healthy population versus NMSC patients. Using a protocol that achieved virtually 
complete depletion of epidermal LCs from UV irradiated skin, they found that 
approximately 60% of healthy volunteers developed a vigorous CHS to a given dose of 
DNCB painted on the UV-irradiated test site. These individuals were designated UVB-
resistant, and were distinguished from other individuals who were designated UVB 
susceptible, by their failure to develop CHS. They then discovered that more than 90% of 
skin cancer patients exposed to UVB and DNCB failed to develop CHS, i.e. were UVB-
susceptible. In subsequent experiments, epicutaneous application of the same dose of DNCB 
to unirradiated skin of UVB-susceptible individuals revealed a further distinction between 
normal persons and skin cancer patients. Approximately 45% of the latter (and none of the 
former) remained unresponsive, implying that they had been rendered immunologically 
tolerant. Because the incidence of UVB-susceptibility was significantly higher in skin cancer 
patients, and as specific unresponsiveness could be demonstrated only in these patients, it 
was proposed that UVB-susceptibility might be a risk factor for the development of skin 
cancer. Indeed, if patients with PLE have a general increased resistance to UV-induced 
immunosuppression, this may make them more resistant to UV carcinogenesis. In an earlier 
case–control study (Wolf et al., 1998), using a questionnaire for phenotypic markers and 
sunlight-related factors and habits, it was observed that UV-induced skin rashes indicative 
of PLE, were recalled by 12% (22/183) of melanoma patients compared with 18% (57/315) of 
healthy control subjects. Although not statistically significant, these results suggest that 
PLE-susceptible patients, possibly being more resistant to UV-induced immunosuppression, 
may have a lower melanoma risk. This hypothesis is supported by the results of a recent 
study by Lembo et al. who investigated the link between PLE and skin cancer prevalence. 
They performed two prospective case–control studies analysing a group comprising 214 
patients with SC and 210 gender-and aged-matched controls (study A), and a group 
comprising 100 patients with PLE and 155 gender- and aged matched controls (study B). 
Skin type and cumulative exposure to UVR were documented. Three sun exposure levels, 
depending on lifestyle, were identified in different sections of the questionnaire designed 
for the survay, investigating work (in/outdoors) and free time (in/outdoors) activities. 
Their results showed that the prevalence of (histologically confirmed) SC in the PLE group 
was 4%; the prevalence of SC in the PLE matched control group was 7.1%, which is similar 
to the National Cancer Registry of Ireland figure of 6% prevalence of SC in the general 
population, with a cumulative risk of 12.5% by the 8th decade. These studies show that there 
is a reduced incidence of SC in patients with PLE compared with gender- and age-matched 
controls. There is less evidence of a reduced incidence of PLE in patients with SC compared 
with controls: the study size was too small to determine this and only a trend was observed. 
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One study of patients with melanoma showed sensitivity of LCs to the effects of solar-
simulated radiation compared with controls. There has been much speculation as to the role 
of LCs in the induction of anti-tumour  immunity. Whereas there is considerable 
circumstantial evidence that disruption in the density and function of these cells during the 
early stages of UVR-induced carcinogenesis may be important for enabling developing 
neoplasms to escape immune destruction, the role of the large number of LC infiltrating 
developed skin tumours is less clear. Interestingly, people “costumes and fashion” are not 
influenced by photoallergy or photoinduced SC. It might be expected that people change 
their behaviour in the sun after being affected by either SC or PLE. Surprisingly, as shown in 
multiple surveys, most subjects with a history of SC were not inclined to use regular 
sunscreen (Moloney et al., 2005). Awareness about sun exposure and SC risk does not 
necessarily influence patients’ sun protection behaviour. Although people are aware of the 
risks of sunbathing, they continue to expose themselves to the sun without taking 
precautions, in accordance with the long-established habits of ‘sun holidays’ and sunbathing 
and the social belief that tanned skin is more aesthetically pleasing. Similarly, although 
patients with PLE might be expected to avoid the sun, many continued to go for sunny 
holidays despite their skin eruption. PLE patients recall more sun exposure than controls 
and in many cases have equivalent sun exposure to patients with SC.  
 
 
 
 
Fig. 2. Pathogenesis of skin cancers and PLE.  
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The schematic diagram highlights the potential pathway of inhibited ultraviolet radiation 
(UVR)-induced immune suppression in patients with polymorphic light eruption. In 
patients with PLE, a persistence of Langerhans cells and failure of UV-induced immune 
suppression may favour the occurrence of autoimmunogenic skin rashes. In normal 
subjects, concurrent UV-induced immunosuppression represent a risk factor for the skin 
cancers. The resistance to UVR-induce immunosuppression of PLE may prevent skin 
cancers risk as the immunosuppression that occurs in skin cancer may prevent PLE 
development. 
6. Conclusion 
A better understanding of UV-induce immunosuppression, leading to SC, and UV-induce 
immunoactivation, provoking PLE, may be helpful in preventing and treating these 
conditions. Therefore, it would be very useful to have a reliable cumulative sun exposure 
dose biomarker, which, related to every single case, could be a predictive factor for SC 
development. SC, up to date, remains the most common human malignancy and, its 
occurance is manly linked to UVR exposure. Immunosurveillance inefficiency or disruption 
of biological pathways of damage repair or programmed cells death, are additive 
mechanisms permitting progression of the neoplastic process initiated by UVR.   
Despite these new insights, in fact, excessive and chronic natural, as well as artificial UVR 
exposure will, however, remain one of the major environmental threats for human health. 
Various skin cancer task forces have proposed several important guidelines to decrease the 
rising skin cancer incidence. These briefly include the following: (1) the establishment of 
policies that reduce exposure to UVR; (2) providing and maintaining physical and social 
environments, which support sun safety and are consistent with the development of other 
healthful habits; (3) professional pre-service and in-service skin cancer education for school 
administrators, teachers, physical education teachers and coaches, nurses, and others 
working in healthcare; (4) health services and organizations to increase skin cancer 
prevention education, sun-safety environments and making these policies readily available 
to the public; (5) lastly, the promotion of free skin cancer screening programs are also highly 
encouraged. Primary care physicians can have greater role in preventing skin cancer if they 
are trained to recognize it and able to educate patients to appropriate sun exposure and 
periodical dermatological consults. Therefore, there is a need for education related to UV 
exposure and skin cancer risk. To address this issue, it would be beneficial to implement 
educational programs tailored for schools/workplaces, homes and doctors’ visits. Patient 
education can include advice pertaining to sunscreen usage, reapplication methods, risk 
factors and tanning bed dangers. In addition to this, visual aids can be valuable in 
physicians’ offices, as they can display the results of people after receiving a great deal of 
UVR. Sun protection strategies utilized for promote safe sun behaviours are resumed in: (1) 
setting a date to end intentional tanning, (2) determining which past behaviors were helpful 
in protecting against sun exposure and trying to incorporate them (as well as other 
techniques) in the future, (3) making strategies to overcome obstacles and (4) involving 
family members so everyone would remind each other about using sun protection. 
Application and promotion of sun protective techniques in children will reduce their 
cumulative lifelong sun exposure and intense episodic sun exposure, hence reducing their 
risk for skin cancer. 
www.intechopen.com
 Photodermatoses and Skin Cancer 
 
27 
7. References  
Agar, N.S.,  Halliday, G.M., Barnetson, R.S., Ananthaswamy, H.N., Wheeler, M., Jones, A.M. 
(2004). The basal layer in human squamous tumors harbors more UVA than UVB 
fingerprint mutations: a role for UVA in human skin  carcinogenesis. Proc. Natl. 
Acad. Sci. U.S.A., Vol. , No. 14, (April 2004), pp. 4954–4959.  
Andrews, F.J., Halliday, G.M., Muller, H.K. (1991). A role for prostaglandins in the 
suppression of cutaneous cellular immunity and tumour development in 
benzo(a)pyrene-treated mice but not dimethylbenz(a)anthracene-treated mice.  
Clin. Exp. Immunol., Vol. 85, No. 1, (July 1991), pp. 9–13. 
Arad, S., Konnikov, N., Goukassian, DA., Gilchrest, BA. (2006) T-oligos augment UV-
induced protective responses in human skin. FASEB J., Vol. 20, No. 11, (September 
2006), pp. 1895–1897. 
Balkwill, F., Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet, Vol.  
357, No. 9255, (February 2001), pp. 539–545. 
Beattie, PE., Dawe, RS., Ibbotson, SH., Ferguson, J. (2003).  Characteristics and prognosis of 
idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol., Vol. 139, No. 9, 
(September  2003), pp. 1149-1154. 
Brenner M, Hearing VJ. (2008). The Protective Role of Melanin Against UV Damage in 
Human Skin. Photochem Photobiol Vol. 84, No. 3, (June  2008), pp. 539–549. 
Caccialanza, M., Percivalle, S., Piccinno, R., Brambilla, R. (2007). Photoprotective activity of 
oral polypodium leucotomos extract in 25 patients with idiopathic 
photodermatoses. Photodermatol Photoimmunol Photomed, Vol. 23, No. 1, (February 
2007), pp. 46–47. 
Cooper, KD., Oberhelman, L., Hamilton, TA. (1992). UV exposure reduces immunization 
rates and promotes tolerance to epicutaneous antigens in humans: relationship to 
dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. 
Proc Natl Acad Sci USA Vol. 89, No. 18, (September  1992), pp. 8497– 8501. 
Darvay, A., White, IR., Rycroft, RJ., Jones, AB., Hawk, JL., McFadden, JP. (2001). 
Photoallergic contact dermatitis is uncommon. Photochem Photobiol, Vol. 145, No. 4, 
(October 2001), pp. 532–536. 
Diffey, BL. Sources and measurement of ultraviolet radiation. (2002). Methods, Vol. 28, No. 1, 
(September 2002), pp. 4-13. 
Eberlein-Konig, B., Fesq, H., Abeck, D., Przybilla, B., Placzek, M., Ring, J. (2000). Systemic 
vitamin C and vitamin E do not prevent photoprovocation test reactions in 
polymorphous light eruption. Photodermatol Photoimmunol Photomed, Vol. 16, No. 2, 
(April  2000), pp. 50–52. 
Epstein, JH. (1986). Polymorphous light eruption. Dermatol Clin Vol. 4, No. 2, (April 1986), 
pp. 243-251. 
Fisher, MS., Kripke, ML. (1997). Systemic alteration induced in mice by ultraviolet light 
irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci U S 
A, Vol. 74, No. 4, (April 1977), pp.1688-1692. 
Ghoreishi, M., Dutz, JP. (2006). Tolerance induction by transcutaneous immunization 
through ultraviolet-irradiated skin is transferable through CD4+CD25+ T 
regulatory cells and is dependent on host derived IL-10. J Immunol., Vol. 176, No.4, 
(February 2006) pp. 2635-2644. 
www.intechopen.com
 Skin Cancer Overview 
 
28
Glanz, K., Buller, DB., Saraiya, M. (2007). Reducing ultraviolet radiation exposure among 
outdoor workers: state of the evidence and recommendations. Environ Health, Vol. 8 
(August 2007), pp. 22. 
Gloster, HM., Neal, K. Skin cancer in skin of color. (2006). J Am Acad Dermatol., Vol. 55, No. 5, 
(November 2006), pp. 761-764. 
Hampton, PJ., Farr, PM., Diffey, BL., Lloyd JJ. (2004). Implication for photosensitive patients 
of ultraviolet A exposure in vehicles. Br J Dermatol, Vol. 151, No. 4, (October  2004), 
pp. 873–876. 
Hiramoto, K., Tanaka, H., Yanagihara, N., Sato, EF., Inoue, M. (2004). Effect of 
17betaestradiol on immunosuppression induced by ultraviolet B irradiation. Arch 
Dermatol Res  Vol. 95, No. 8, (February 2004), pp. 307–311. 
Janssens, AS., Pavel, S., Ling, T., Winhoven, SM. (2007). Arch Dermatol, Vol. 143, No. 5, (May 
2007), pp. 599–604. 
Janssens, AS., Pavel, S., Out-Luiting, JJ., Willemze, R., de Gruijl, FR. (2005). Normalized 
ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates 
after artificial UVB hardening of patients with polymorphic light eruption. Br J 
Dermatol  Vol. 152, No. 6, (Jun 2005), pp. 1268–1274. 
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, MJ. (2007). Cancer Statistics, 2007. 
Cancer Journal for Clinicians, Vol. 57, pp. 43–66.  
Johnston, GA. (2002). Thiazide-induced lichenoid photosensitivity. Clin Exp Dermatol  Vol. 
27, No. 8, (November 2002), pp. 670 672. 
K¨olgen, W., van Meurs, M., Jongsma, M, van Weelden, H., Bruijnzeel-Koomen, CA., Knol, 
EF., van Vloten, WA., Laman, J., de Gruijl, FR. (2004). Differential expression of 
cytokines in UV-B-exposed skin of patients with polymorphous light eruption: 
correlation with Langerhans cell migration and immunosuppression. Arch 
Dermatol, Vol. 140, No. 3, (March 2004), pp. 295–302. 
Kontos, AP., Cusack, CA., Chaffins, M., Lim, HW. Polymorphous light eruption in African 
Americans: pinpoint papular variant. Photodermatol Photoimmunol Photomed  Vol. 18, 
No. 6, (December 2002), pp. 303–306. 
Lautenschlager, S., Wulf, HC., Pittelkow, MR. (2007).  Photoprotection. Lancet  Vol. 370, No. 
9586, (August  2007), pp. 528–537. 
Lembo, S., Fallon, J., O’Kelly, P., Murphy, GM. (2008). Polymorphic light eruption and skin 
cancer prevalence: is one protective against the other? Br J Dermatol  Vol. 159, No. 6, 
(December  2008), pp.1342–1347. 
Leverrier, S., Bergamaschi, D., Ghali, L. Ola, A., Warnes, G., Akgül, B., Blight, K., García-
Escudero, R., Penna, A., Eddaoudi, A., Storey, A. (2007). Role of HPV E6 proteins 
inpreventing UVB-induced release of pro-apoptotic factors from the mitochondria. 
Apoptosis Vol. 12, No. 3, (March 2007), pp. 549–560. 
Ma, F., Collado-Mesa, F., Hu, S., Kirsner RS. (2007). Skin cancer awareness and sun 
protection behaviors in white 
Hispanic and white non-Hispanic high school students in Miami, Florida. Arch Dermatol, 
Vol. 143, No. 8, (August 2007), pp. 983–988. 
McLoone, P., Simics, E., Barton, A. Norval, M., Gibbs, NK. (2005).  An action spectrum for 
the production of cis-urocanic acid in human skin in vivo. J Invest Dermatol,  Vol. 
124, No. 5, (May 2005), pp. 1071–1074. 
www.intechopen.com
 Photodermatoses and Skin Cancer 
 
29 
Moyal, D.D., Fourtanier, A.M. (2001). Broad-spectrum sunscreens provide better protection 
from the suppression of the elicitation phase of delayed-type hypersensitivity 
response in humans. J Invest. Dermatol., Vol. 117, No. 5, (November 2001), pp. 
1186–1192. 
Murphy GM. (2001). Diseases associated with photosensitivity. J Photochem Photobiol , Vol. 
64, pp. 93–98. 
Murphy, GM., Wright, J., Nicholls, DS., McKee, PH., Messenger, AG., Hawk, JL., Levene, 
GM. (1989). Sunbed-induced pseudoporphyria. Br J Dermatol  Vol. 120, No. 4, (April 
1989), pp. 555–562. 
O’Connor, DP., Kay, EW., Leader M., Murphy, GM., Atkins, GJ., Mabruk, MJ. (2001). 
Altered p53e expression in benign and malignant skin lesions from renal transplant 
recipients and immunocompetent patients with skin cancer: correlation with 
human papillomaviruses? Diagn Mol Pathol  Vol. 10, No. 32, (September 2001), pp. 
190–199. 
Ou-Yang, H., Stamatas, G., Saliou, C., Kollias, N. (2004). A chemiluminescence study of 
UVA-induced oxidative stress in human skin in vivo.  J Invest Dermatol. Vol. 122, 
No. 4, (April 2004) , pp. 1020–1029. 
Palmer, RA., Friedmann, PS. (2004). Ultraviolet radiation causes less immunosuppression in 
patients with polymorphic light eruption than in controls. J Invest Dermatol Vol. 
122, No. 2, (February 2004), pp. 291–294. 
Palmer, RA., Hawk, JL., Young, AR., Walker SL. (2005). The effect of solarsimulated 
radiation on the elicitation phase of contact hypersensitivity does not differ 
between controls and patients with polymorphic light eruption. J Invest Dermatol  
Vol. 124, No. 6, (June 2005), pp. 467–470. 
Patel, DC., Bellaney, GJ., Seed, PT., McGregor, JM., Hawk, JL. (2000). Efficacy of short-course 
oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J 
Dermatol Vol. 143, No. 4, (October 2000), pp. 828–831. 
Paulson, KG., Lemos, BD., Feng, B. Jaimes, N., Peñas, PF., Bi, X., Maher, E., Cohen, L., 
Leonard, JH., Granter, SR., Chin, L., Nghiem, P. (2009). Array-CGH reveals 
recurrent genomic changes in Merkel cell carcinoma including amplification of L-
Myc. J Invest Dermatol  Vol. 129, No. 6, (June 2009), pp. 1547–55. 
Phillipson, R.P., Tobi, S.E.,. Morris, J.A, McMillan, T.J. (2002). UV-A induces persistent 
genomic instability in human keratinocytes through an oxidative stress mechanism, 
Free Radic. Biol. Med. Vol. 32, No. 5, (March 2002), pp. 474–480. 
Rhee,  JS., Matthews, BA., Neuburg, M., Logan BR., Burzynski, M., Nattinger, AB. (2007). 
The skin cancer index: clinical responsiveness and predictors of quality of life. 
Laryngoscope Vol. 117, No. 3, (March 2007), pp. 399–405. 
Rittié, L., Kansra, S., Stoll, SW., Li, Y., Gudjonsson, JE., Shao, Y., Michael, LE., Fisher, GJ., 
Johnson, TM., Elder, JT. (2007). Differential ErbB1 signaling in squamous cell versus 
basal cell carcinoma of the skin. Am J Pathol Vol. 170, No. 6 (June 2007), pp. 2089–
2099. 
Ross JA, Howie SE, Norval M et al. Ultraviolet-irradiated urocanic acid suppresses delayed-
type hypersensitivity to herpes simplex virus in mice. J Invest Dermatol 1986; 
87:630–3. 
Shipley, DR., Hewitt, JB. (2001).  Polymorphic light eruption treated with cyclosporin. Br J 
Dermatol  Vol. 144, No. 2, (February 2001), pp. 446–447. 
www.intechopen.com
 Skin Cancer Overview 
 
30
Stratigos, AJ., Antoniou, C., Katsambas, AD. (2002). Polymorphous light eruption. J Eur Acad 
Dermatol Venereol  Vol. 16, No. 3, (May  2002), pp. 193–206. 
Suárez, B., López-Abente, G., Martínez, C., Navarro, C., Tormo, MJ., Rosso, S., Schraub, S., 
Gafà, L., Sancho-Garnier, H., Wechsler, J., Zanetti, R. (2007). Occupation and skin 
cancer: the results of the HELIOS-I multicenter case-control study. BMC Public 
Health Vol. 26, No. 7, (July 2007), pp. 180 
Thompson, E.J., Gupta, A., Vielhauer, G.A., Regan, J.W., Bowden, G.T. (2008). The growth of 
malignant keratinocytes depends on signaling through the PGE2 receptor EP1, 
Neoplasia Vol. 3, No. 5, (September 2001), pp. 402–410. 
Timares, L., Katiyar, SK., Elmets, CA. (2008). DNA damage, apoptosis and langerhans cells – 
Activators of UV-induced immune tolerance. Photochem Photobiol  Vol. 84, No. 2, 
(April 2008), pp.422–436. 
van de Pas, CB., Kelly, DA., Seed, PT., Young, AR., Hawk, JL., Walker, SL. (2004). 
Ultraviolet-radiationinduced erythema and suppression of contact hypersensitivity 
responses in patients with polymorphic light eruption. J InvestDermatol Vol. 122, 
No. 2, (February 2004), pp. 295–299. 
Vural, P., Canbaz, M., Selcuki, D. (1999). Plasma antioxidant defense in actinic keratosis and 
basal cell carcinoma, J. Eur. Acad. Dermatol. Venereol. Vol. 13, No. 2 (September 
1999), pp. 96–101. 
Walterscheid, J.P., Ullrich, S.E.,. Nghiem, D.X. Plateletactivating factor, a molecular sensor 
for cellular damage, activates systemic immune suppression. (2002).  J. Exp. Med.  
Vol. 195, No. 2, (January 2002), pp. 171–179. 
Warren J.B. (1994). Nitric oxide and human skin blood flow responses to acetylcholine and 
ultraviolet light. FASEBJ., Vol. 8, No. 2, (February 1994), pp. 247–251. 
Whiteman, DC., Whiteman, CA., Green, AC. (2001). Childhood sun exposure as a risk factor 
for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control, 
Vol. 12, No. 1, (January  2001), pp. 69–82. 
Widyarini, S., Domanski, D., Painter, N., Reeve, V E. (2006). Estrogen receptor signalling 
protects against immune suppression by UV radiation exposure. Proc Natl Acad Sci 
USA Vol. 103, No. 34, (August  2006), pp. 12837–12842. 
Wolf, P., Quehenberger, F., Mullegger, R., Stranz, B., Kerl, H. (1998). Phenotypic markers, 
sunlight-related factors and sunscreen use in patients with cutaneous melanoma: 
an Austrian case–control study. Melanoma Res  Vol. 8, No. 4, (August  1998), pp. 
370–378. 
Wong, SN., Khoo, LS. (2003). Chronic actinic dermatitis as the presenting feature of HIV 
infection in three Chinese males. Clin Exp Dermatol  Vol. 28, No. 3, (May 2003), pp. 
265–268. 
World Health Organization. Skin cancers [online]. Available from URL:  
 http://www.who.int/uv/faq/skin cancer/en/print.html.  
 [Accessed 2009 September 14]. 
Yoshikawa, T., Rae, V., Bruins-Slot, W., Van den Berg, J W., Taylor, J R., Streilein, J W. 
(1990). Susceptibility to effects of UVB radiation on induction of contact 
hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol Vol. 95, 
No. 5, (November 1990), pp. 9530–9536. 
www.intechopen.com
Skin Cancer Overview
Edited by Dr. Yaguang Xi
ISBN 978-953-307-746-8
Hard cover, 214 pages
Publisher InTech
Published online 16, December, 2011
Published in print edition December, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The book Skin Cancer Overview is divided into three sections to cover the most essential topics in skin cancer
research: Etiology, Diagnosis and Treatment, and Prevention. Due to the complexity of skin cancer, this book
attempts to not only provide the basic knowledge, but also present the novel trends of skin cancer research. All
chapters were written by experts from around the world. It will be a good handbook for researchers with
interests in skin cancer.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Serena Lembo, Nicola Balato, Annunziata Raimondo, Martina Mattii, Anna Balato and Giuseppe Monfrecola
(2011). Photodermatoses and Skin Cancer, Skin Cancer Overview, Dr. Yaguang Xi (Ed.), ISBN: 978-953-307-
746-8, InTech, Available from: http://www.intechopen.com/books/skin-cancer-overview/photodermatoses-and-
skin-cancer
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
